Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?

To: Stephen M. DeMoss who wrote (763)	3/21/1998 12:01:00 PM
From: Mikey	Read Replies (1) \| Respond to of 1055

Actually, for stocks like THRX, yesterday was not an "up" market. You'll note that the Nasdaq lost 11 points yesterday. The Dow and S&P were up siginificantly, but on a day the Dow is up 100 and the S&P is up 10, the Nasday should be up 20. So the Nasdaq ended the day 30 points lower than the normal ratio would suggest. That's not an up market. I think this is due to mutual fund managers just throwing money at the Dow and S&P stocks. Most of my portfolio has been doing really well lately, with a lot of momentum, and a lot of those stocks closed down for the day, because they are smaller companies and most of them are Nasdaq listed. The Nasdaq made a reversal bar, and the last day it did that was on 3/2 before reaching a short-term low four days later. In terms of some indicators, the Nasdaq has led the Dow and S&P in some ways in the last few years. For THRX in specific, it still hasn't reached my sell signal for the top Bollinger Band. But yesterday it did break a short-term up trendline, but certainly not by 2-3%, so it may rally back up to that trendline which would be around 67 3/4 on Monday, although it may not rally back up to it right away (ie Might not be on Monday). However, if the overall market goes lower for three or four days THRX might move short-term lower. I see absolutely no indicators that show a primary trend change or anything yet. Yes, it might be way overvalued, but it also might become a lot more overvalued in the next three months. M.

To: Stephen M. DeMoss who wrote (763)	3/21/1998 8:21:00 PM
From: SKARLOEY	Read Replies (1) \| Respond to of 1055

the potential is so great for not just prostate cancer, but for many other cancers, that the upside is what people see in this stock. the dollar cost savings to health care will be substantial. minimally invasive, less recoup time, these are just a few. i would quess with all the bright people on this thread, we could list out ten or more other ways this procedure will cut med. exp. also, with big cap stocks stoking to new highs, the smart money is looking at the small and mid cap stocks for big big gains. sm. and mid cap health care have been overlooked imo for quite a number of years.